MENU
+Compare
INO
Stock ticker: NASDAQ
AS OF
Jun 3 closing price
Price
$2.12
Change
+$0.02 (+0.95%)
Capitalization
77.75M

INO Inovio Pharmaceuticals Forecast, Technical & Fundamental Analysis

Inovio Pharmaceuticals Inc is a United States-based biotechnology company... Show more

INO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for INO with price predictions
Jun 02, 2025

Momentum Indicator for INO turns positive, indicating new upward trend

INO saw its Momentum Indicator move above the 0 level on May 15, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 76 similar instances where the indicator turned positive. In of the 76 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for INO just turned positive on May 12, 2025. Looking at past instances where INO's MACD turned positive, the stock continued to rise in of 43 cases over the following month. The odds of a continued upward trend are .

INO moved above its 50-day moving average on May 12, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for INO crossed bullishly above the 50-day moving average on May 01, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where INO advanced for three days, in of 225 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 132 cases where INO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for INO moved out of overbought territory on May 21, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 15 similar instances where the indicator moved out of overbought territory. In of the 15 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 45 cases where INO's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where INO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.517) is normal, around the industry mean (17.331). P/E Ratio (0.000) is within average values for comparable stocks, (59.245). INO's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.227). Dividend Yield (0.000) settles around the average of (0.038) among similar stocks. P/S Ratio (232.558) is also within normal values, averaging (261.682).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. INO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. INO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
INO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

INO is expected to report earnings to rise 141.18% to -123 cents per share on March 13

Inovio Pharmaceuticals INO Stock Earnings Reports
Q4'23
Est.
$-1.23
Q1'25
Beat
by $0.65
Q3'23
Beat
by $0.04
Q2'23
Beat
by $0.02
Q1'23
Beat
by $0.31
The last earnings report on May 13 showed earnings per share of -50 cents, beating the estimate of -115 cents. With 592.25K shares outstanding, the current market capitalization sits at 77.75M.
A.I. Advisor
published General Information

General Information

a developer of synthetic vaccines and immune therapies for cancers and infectious diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
660 West Germantown Pike
Phone
+1 267 440-4200
Employees
122
Web
https://www.inovio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TNYA0.490.03
+6.52%
Tenaya Therapeutics
LMB134.971.81
+1.36%
Limbach Holdings
MGPI29.580.37
+1.27%
MGP Ingredients
ABBV187.250.26
+0.14%
ABBVIE
EAT173.36-2.56
-1.46%
Brinker International

INO and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, INO has been loosely correlated with RPTX. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if INO jumps, then RPTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INO
1D Price
Change %
INO100%
+0.95%
RPTX - INO
59%
Loosely correlated
+5.84%
BCYC - INO
56%
Loosely correlated
-2.92%
AXON - INO
53%
Loosely correlated
+0.07%
ARRY - INO
52%
Loosely correlated
+6.53%
ONCO - INO
50%
Loosely correlated
-5.00%
More